Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
NCT ID: NCT00828633
Last Updated: 2018-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
92 participants
OBSERVATIONAL
2008-08-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symptom Management in African-American Men With Localized Prostate Cancer
NCT00767845
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer
NCT00582842
A Study of BAY 43-9006 in Combination With Bicalutamide in Patients With Chemo-Naïve Hormone Refractory Prostate Cancer
NCT00430235
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT06145633
Study of Treatment Choice in Patients With Localized Prostate Cancer
NCT01177865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To enroll 200 gay men with localized prostate cancer in a cross-sectional study of prostate cancer outcomes.
* To complete an R01 application using pilot data collected from these patients.
* To complete manuscripts describing the factors that influence quality of life and treatment satisfaction in these patients.
OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of healthcare services \[e.g., oral medications for erectile dysfunction\]), symptom distress, and psychosocial factors (ethnicity, health literacy, level of social support, communication with provider, relationship status, and communication with partner) that affect their health-related quality of life. The data will be used to provide the information necessary to tailor an existing prostate cancer survivorship intervention to address the specific needs of gay men with prostate cancer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of localized prostate cancer
* No advanced disease
* Self-identified as gay
PATIENT CHARACTERISTICS:
* Able to complete an online questionnaire
* Able to speak and understand English
PRIOR CONCURRENT THERAPY:
* Not specified
18 Years
100 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baylor College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Latini
Adjunct Assistant Professor of Urology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David M. Latini, PhD
Role: PRINCIPAL_INVESTIGATOR
Baylor College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dan L. Duncan Cancer Center at Baylor College of Medicine
Houston, Texas, United States
Veterans Affairs Medical Center - Houston
Houston, Texas, United States
Ryerson University
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BCM-H-21892
Identifier Type: OTHER
Identifier Source: secondary_id
CDR0000600597
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.